Developer docs
API playgroundTry for free, no card

Search company profiles

Cognivive, Inc.

Full company profile

uuid00047bh

Namestring
Cognivive, Inc.
Legal namestring
Cognivive, Inc.
Websiteurl
cognivive.com
Company typeenum
Private
Founded yearint
2017
Descriptiontext

Cognivive, Inc. is a private digital neurotherapeutics company founded in 2017 and headquartered in Davis, California, that develops CogniviveVR, a fully-immersive virtual reality platform for at-home stroke rehabilitation. The platform delivers therapeutic games designed as commercial-quality video experiences that adapt their difficulty in real time based on each patient's performance, targeting neuroplasticity through intensive, repetitive upper-extremity exercises. Treatment modules are evidence-based, drawing on what the company describes as decades of underlying scientific research, and are positioned as digital medicines that patients can self-administer after leaving clinical settings. The company explicitly identifies the extension of rehabilitation beyond the clinic walls as the core problem being solved.

Cognivive operates a hybrid go-to-market: an enterprise field-sales motion with a 'Schedule a Demo' call-to-action targeting healthcare providers and rehabilitation facilities, paired with a direct-to-consumer at-home distribution channel that allows stroke patients to access VR therapy independently. Revenue is generated via subscription-based access to the VR therapeutic software, although pricing is not publicly disclosed. The primary customer segment is stroke rehabilitation patients needing post-clinic therapy, with a secondary segment comprising patients with broader neurological conditions including Alzheimer's and Parkinson's disease.

Operationally, Cognivive remains an early-stage company with 1–10 employees, no disclosed institutional venture capital, and approximately $845,000 in cumulative disclosed funding across 2017–2020. Leadership consists of CEO Tony Simon and Joseph Salisbury as Head of Digital Therapeutics. The product targets a large addressable market — global digital health in neurology estimated at $38 billion in 2024 and projected to grow to $296.3 billion by 2034 — but as of the available data, the company has no disclosed FDA clearance, no named enterprise customers, no patents, and no formal strategic partnerships, making it a pre-commercial-stage platform with significant clinical validation and go-to-market execution ahead.

Short descriptiontext

Cognivive, Inc. is a private digital neurotherapeutics company founded in 2017 that develops CogniviveVR, an adaptive virtual reality platform enabling stroke patients to self-administer evidence-based upper-extremity rehabilitation therapy at home. The company also targets broader neurological conditions including Alzheimer's and Parkinson's disease.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersDavis, United States
HQ citystring
Davis
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
digital therapeutics, virtual reality therapy, stroke rehabilitation, neuroplasticity therapy, VR healthcare
Industry4 codes
PRIMARYHLACANAI
Behavioral Health & Neurocognitive Therapeutics (Digital)
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
SECONDARYHLACANAJ
Digital Rehabilitation & Physical Therapy Therapeutics
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
SECONDARYHSADAIAC
Neurologic Rehabilitation (Stroke, TBI, Parkinson’s, MS)
Home & Personal Services/Fitness, Wellness & Personal Training/Physical Therapy, Rehabilitation & Corrective Exercise
SECONDARYHSABADAE
Neurological Rehabilitation Therapy In-Home (e.g., Stroke, Parkinson’s)
Home & Personal Services/Elder Care & In-Home Care Services/Rehabilitation Therapy (PT/OT/SLP) In-Home
NAICS code2 codes
  • Home Health Care Services62161
  • Software Publishers5132
SIC code2 codes
  • Services-Home Health Care Services8082
  • Services-Prepackaged Software7372
Product category
Digital Therapeutics
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1VR Therapeutic Software Subscription
TypeSubscription Recurring
Description

Cognivive generates revenue through subscription-based access to its VR therapeutic games and treatment modules, delivered as digital medicines for at-home stroke rehabilitation. The model supports long-term patient adherence with progressive difficulty scaling as patients' abilities improve.

cognivive.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Technology or R&D, Marketing or Sales, Operations
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 record
1CogniviveVR
Description

Virtual reality therapeutic product line for stroke rehabilitation treatment games designed for patients to use at home.

cognivive.com
Core offering1 text field

Cognivive develops and sells CogniviveVR, a fully-immersive virtual reality therapeutic platform that enables stroke patients to self-administer rehabilitation therapy at home. The platform delivers adaptive treatment games whose challenge level continuously adjusts in real time to each patient's performance, targeting neuroplasticity through intensive, repetitive upper extremity exercises. Therapeutic activities are designed with commercial-quality video game aesthetics to drive intrinsic motivation and long-term adherence, positioning the product as a digital medicine.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • Facilitates neuroplasticity through greater intensity and repetition of targeted upper extremity exercises
Product overview1 text field

Cognivive offers a single unified therapeutic platform centered on CogniviveVR, an immersive virtual reality system for stroke rehabilitation. The platform provides personalized at-home therapy through adaptive VR games that adjust difficulty in real time based on patient performance, targeting neuroplasticity via repetitive upper extremity exercises. The product is designed as a digital medicine solution with commercial-quality video game aesthetics to promote patient engagement and long-term adherence.

Product and service1 record
1CogniviveVR
CategoryDigital Therapeutics / Virtual Reality Rehabilitation
Description

A fully-immersive virtual reality therapeutic platform that enables stroke patients to self-administer rehabilitation therapy at home. It delivers adaptive treatment games whose challenge level continuously adjusts in real time to each patient's performance, targeting neuroplasticity through intensive, repetitive upper extremity exercises. The product is positioned as a digital medicine and is sold via subscription-based access.

Scale indicator1 record

Each record includes

Type, Value, Description, Source

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Neuro Rehab VR builds VR-based therapy exercises for physical and occupational therapy in clinical and home settings, directly overlapping Cognivive's stroke rehabilitation focus.

TypeDirect peer
Description

MindMaze develops immersive VR-based platforms for neurological recovery, including stroke and brain-injury rehabilitation, making it a direct competitor to Cognivive in adaptive VR neuro-rehabilitation.

TypeDirect peer
Description

Penumbra's REAL System is a clinically validated VR platform for upper and lower extremity rehabilitation in stroke and other neurological conditions, directly competing with CogniviveVR in clinical rehab settings.

TypeDirect peer
Description

Constant Therapy Health offers a digital neurotherapy platform with adaptive cognitive and speech exercises for stroke and TBI recovery, providing a directly comparable digital neurotherapeutic model.

TypeBroad incumbent
Description

Saebo is an established provider of stroke rehabilitation products and clinical education, addressing the same patient population and therapy continuum as Cognivive but with a broader portfolio of physical rehab devices.

6XRHealth
TypeBroad incumbent
Description

XRHealth operates a VR-based telehealth therapy platform across multiple neurological and mental health indications, competing with Cognivive in VR neurotherapeutic delivery and remote patient monitoring.

TypeBroad incumbent
Description

AppliedVR develops FDA-authorized VR therapeutics, primarily for chronic pain, with a digital-therapeutic regulatory and commercialization approach comparable to Cognivive's pathway.

TypeEmerging player
Description

BehaVR builds immersive VR therapeutics for mental health and behavioral conditions, sharing Cognivive's VR-as-digital-medicine model while focusing on a different therapeutic vertical.

TypeBroad incumbent
Description

NeuroPace is an established neurotechnology company offering the RNS System for epilepsy, addressing adjacent neurological populations with regulated digital/neuro device offerings similar to Cognivive's regulatory ambitions.

TypeEmerging player
Description

Limbic uses AI-driven personalization for mental health and rehabilitation applications, sharing the adaptive, data-driven therapy approach that Cognivive applies to stroke rehab.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds4 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Cognivive, Inc.

Digital Therapeuticscognivive.com

Cognivive, Inc. is a private digital neurotherapeutics company founded in 2017 that develops CogniviveVR, an adaptive virtual reality platform enabling stroke patients to self-administer evidence-based upper-extremity rehabilitation therapy at home. The company also targets broader neurological conditions including Alzheimer's and Parkinson's disease.

What Cognivive, Inc. does

Cognivive, Inc. is a private digital neurotherapeutics company founded in 2017 and headquartered in Davis, California, that develops CogniviveVR, a fully-immersive virtual reality platform for at-home stroke rehabilitation. The platform delivers therapeutic games designed as commercial-quality video experiences that adapt their difficulty in real time based on each patient's performance, targeting neuroplasticity through intensive, repetitive upper-extremity exercises. Treatment modules are evidence-based, drawing on what the company describes as decades of underlying scientific research, and are positioned as digital medicines that patients can self-administer after leaving clinical settings. The company explicitly identifies the extension of rehabilitation beyond the clinic walls as the core problem being solved.

Cognivive operates a hybrid go-to-market: an enterprise field-sales motion with a 'Schedule a Demo' call-to-action targeting healthcare providers and rehabilitation facilities, paired with a direct-to-consumer at-home distribution channel that allows stroke patients to access VR therapy independently. Revenue is generated via subscription-based access to the VR therapeutic software, although pricing is not publicly disclosed. The primary customer segment is stroke rehabilitation patients needing post-clinic therapy, with a secondary segment comprising patients with broader neurological conditions including Alzheimer's and Parkinson's disease.

Operationally, Cognivive remains an early-stage company with 1–10 employees, no disclosed institutional venture capital, and approximately $845,000 in cumulative disclosed funding across 2017–2020. Leadership consists of CEO Tony Simon and Joseph Salisbury as Head of Digital Therapeutics. The product targets a large addressable market — global digital health in neurology estimated at $38 billion in 2024 and projected to grow to $296.3 billion by 2034 — but as of the available data, the company has no disclosed FDA clearance, no named enterprise customers, no patents, and no formal strategic partnerships, making it a pre-commercial-stage platform with significant clinical validation and go-to-market execution ahead.

Cognivive, Inc. firmographics

Firmographics
Name
Cognivive, Inc.
Legal name
Cognivive, Inc.
Website
https://cognivive.com
Company type
Private
Founded year
2017
Operating status
Operating
Headcount range
1–10 employees
Short description
Cognivive, Inc. is a private digital neurotherapeutics company founded in 2017 that develops CogniviveVR, an adaptive virtual reality platform enabling stroke patients to self-administer evidence-based upper-extremity rehabilitation therapy at home. The company also targets broader neurological conditions including Alzheimer's and Parkinson's disease.
Ownership category
akta.pro rank

Cognivive, Inc. industry classification

Industry
Product category
Digital Therapeutics
NAICS
Home Health Care Services (62161), Software Publishers (5132)
SIC
Services-Home Health Care Services (8082), Services-Prepackaged Software (7372)
akta.pro industry
PRIMARYHLACANAI
Behavioral Health & Neurocognitive Therapeutics (Digital)
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
SECONDARYHLACANAJ
Digital Rehabilitation & Physical Therapy Therapeutics
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
SECONDARYHSADAIAC
Neurologic Rehabilitation (Stroke, TBI, Parkinson’s, MS)
Home & Personal Services/Fitness, Wellness & Personal Training/Physical Therapy, Rehabilitation & Corrective Exercise
SECONDARYHSABADAE
Neurological Rehabilitation Therapy In-Home (e.g., Stroke, Parkinson’s)
Home & Personal Services/Elder Care & In-Home Care Services/Rehabilitation Therapy (PT/OT/SLP) In-Home

Keywords

  • Digital therapeutics
  • Virtual reality therapy
  • Stroke rehabilitation
  • Neuroplasticity therapy
  • VR healthcare

Where Cognivive, Inc. is headquartered

Location

Headquarters

HQ city
Davis
HQ country
United States
HQ region
North America

Markets served

Cognivive, Inc. business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Marketing or Sales, Operations

Revenue model

  1. VR Therapeutic Software Subscription: Cognivive generates revenue through subscription-based access to its VR therapeutic games and treatment modules, delivered as digital medicines for at-home stroke rehabilitation. The model supports long-term patient adherence with progressive difficulty scaling as patients' abilities improve.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels3 records

Cognivive, Inc. product offering

Product offering

Core offering

Cognivive develops and sells CogniviveVR, a fully-immersive virtual reality therapeutic platform that enables stroke patients to self-administer rehabilitation therapy at home. The platform delivers adaptive treatment games whose challenge level continuously adjusts in real time to each patient's performance, targeting neuroplasticity through intensive, repetitive upper extremity exercises. Therapeutic activities are designed with commercial-quality video game aesthetics to drive intrinsic motivation and long-term adherence, positioning the product as a digital medicine.

Product overview

Cognivive offers a single unified therapeutic platform centered on CogniviveVR, an immersive virtual reality system for stroke rehabilitation. The platform provides personalized at-home therapy through adaptive VR games that adjust difficulty in real time based on patient performance, targeting neuroplasticity via repetitive upper extremity exercises. The product is designed as a digital medicine solution with commercial-quality video game aesthetics to promote patient engagement and long-term adherence.

Differentiator

Problem solved

Functional benefit

Brands

  • CogniviveVR: Virtual reality therapeutic product line for stroke rehabilitation treatment games designed for patients to use at home.

Products and services

  • CogniviveVR A fully-immersive virtual reality therapeutic platform that enables stroke patients to self-administer rehabilitation therapy at home. It delivers adaptive treatment games whose challenge level continuously adjusts in real time to each patient's performance, targeting neuroplasticity through intensive, repetitive upper extremity exercises. The product is positioned as a digital medicine and is sold via subscription-based access.

Quantifiable outcome

  • Facilitates neuroplasticity through greater intensity and repetition of targeted upper extremity exercises

Companies that use Cognivive, Inc.

Customer profile

Segments2 records

Ideal customer profiles2 records

Cognivive, Inc. technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Cognivive, Inc. partnerships and signals

Strategic signal

Scale indicators1 record

Recent moves5 records

Expansion highlights4 records

Cognivive, Inc. competitors and assessment

Company assessment

Direct peers

  • Neuro Rehab VR: Neuro Rehab VR builds VR-based therapy exercises for physical and occupational therapy in clinical and home settings, directly overlapping Cognivive's stroke rehabilitation focus.
  • MindMaze: MindMaze develops immersive VR-based platforms for neurological recovery, including stroke and brain-injury rehabilitation, making it a direct competitor to Cognivive in adaptive VR neuro-rehabilitation.
  • Penumbra (REAL Immersive System): Penumbra's REAL System is a clinically validated VR platform for upper and lower extremity rehabilitation in stroke and other neurological conditions, directly competing with CogniviveVR in clinical rehab settings.
  • Constant Therapy Health: Constant Therapy Health offers a digital neurotherapy platform with adaptive cognitive and speech exercises for stroke and TBI recovery, providing a directly comparable digital neurotherapeutic model.

Broad incumbents

  • Saebo: Saebo is an established provider of stroke rehabilitation products and clinical education, addressing the same patient population and therapy continuum as Cognivive but with a broader portfolio of physical rehab devices.
  • XRHealth: XRHealth operates a VR-based telehealth therapy platform across multiple neurological and mental health indications, competing with Cognivive in VR neurotherapeutic delivery and remote patient monitoring.
  • AppliedVR: AppliedVR develops FDA-authorized VR therapeutics, primarily for chronic pain, with a digital-therapeutic regulatory and commercialization approach comparable to Cognivive's pathway.
  • NeuroPace: NeuroPace is an established neurotechnology company offering the RNS System for epilepsy, addressing adjacent neurological populations with regulated digital/neuro device offerings similar to Cognivive's regulatory ambitions.

Emerging players

  • BehaVR: BehaVR builds immersive VR therapeutics for mental health and behavioral conditions, sharing Cognivive's VR-as-digital-medicine model while focusing on a different therapeutic vertical.
  • Limbic: Limbic uses AI-driven personalization for mental health and rehabilitation applications, sharing the adaptive, data-driven therapy approach that Cognivive applies to stroke rehab.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights6 records

Customer concentration

Cognivive, Inc. social profiles

Digital presence

Cognivive, Inc. financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Cognivive, Inc. leadership team

Management profile

Number of profiles

Profiles2 records

Cognivive, Inc. funding detail

Funding detail

Funding overview

Funding rounds4 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Cognivive, Inc. M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cognivive, Inc.

What does Cognivive, Inc. do?

Cognivive develops and sells CogniviveVR, a fully-immersive virtual reality therapeutic platform that enables stroke patients to self-administer rehabilitation therapy at home. The platform delivers adaptive treatment games whose challenge level continuously adjusts in real time to each patient's performance, targeting neuroplasticity through intensive, repetitive upper extremity exercises. Therapeutic activities are designed with commercial-quality video game aesthetics to drive intrinsic motivation and long-term adherence, positioning the product as a digital medicine.

Is Cognivive, Inc. a public or private company?

Cognivive, Inc. is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Cognivive, Inc. founded?

Cognivive, Inc. was founded in 2017. It employs 1 to 10 people.

Where is Cognivive, Inc. based?

Cognivive, Inc. is headquartered in Davis, United States, in the North America region.

How does Cognivive, Inc. make money?

One revenue line is on record: VR Therapeutic Software Subscription.

Who are Cognivive, Inc.'s main competitors?

Direct peers on record are Neuro Rehab VR, MindMaze, Penumbra (REAL Immersive System) and Constant Therapy Health. Broad incumbents are Saebo, XRHealth, AppliedVR and NeuroPace. Emerging players are BehaVR and Limbic.

Does Cognivive, Inc. have an API?

No public API is recorded for Cognivive, Inc..

What industry is Cognivive, Inc. in?

Cognivive, Inc.'s product category is Digital Therapeutics. Its primary akta.pro industry code is HLACANAI, Behavioral Health & Neurocognitive Therapeutics (Digital), with a secondary code of HLACANAJ, Digital Rehabilitation & Physical Therapy Therapeutics. Its NAICS code is 62161 and its SIC code is 8082.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales